| (S)-2-Amino-N-((S)-2-biphenyl-4-yl-1-cyano-ethyl)-butyramide | IC50 | 2.0 [1], 13.0 [2], 63.1 [3], 6100.0 [4], 10000.0 [5] |
| 4-Amino-N-[(1S)-1-cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]oxane-4-carboxamide | IC50 | 0.79 [1], 1.0 [2], 5.01 [3], 7.94 [4] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(1-methyl-2-oxo-3H-indol-6-yl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 32.2 [1], 52.2 [2] |
| CID 118253852 | IC50 | 3.98 [1] |
| N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-4-methyl-1-oxopentan-2-yl]morpholine-4-carboxamide | IC50 | 2600.0 [1], 4000.0 [2] |
| (S)-2-Amino-N-((S,E)-5-phenyl-1-(phenylsulfonyl)pent-1-en-3-yl)pentanamide | IC50 | 70.0 [1], 100.0 [2] |
| (S)-N-((S)-1-Cyano-2-phenylethyl)pyrrolidine-2-carboxamide | IC50 | 4806.0 [1], 9637.0 [2] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(3,3-difluoro-1-methyl-2-oxoindol-6-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 15.85 [1] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(3,7-dimethyl-2-oxo-1,3-benzoxazol-5-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 7.94 [1], 10.0 [2] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(1-methyl-2-oxoquinolin-7-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 12.59 [1] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(3-methyl-1,2-benzoxazol-5-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 15.85 [1] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 31.62 [1], 39.81 [2] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(4-methyl-3-oxo-1,4-benzoxazin-6-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 12.59 [1] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(3-ethyl-2-oxo-1,3-benzoxazol-5-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 5.01 [1] |
| (2S)-N-[(1S)-1-Cyano-2-[4-[3-(2,2-difluoroethyl)-2-oxo-1,3-benzoxazol-5-yl]phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 6.31 [1] |
| (2S)-N-[(1S)-1-Cyano-2-[4-[5-(trifluoromethyl)pyrimidin-2-yl]phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 199.53 [1] |
| (1S,2S)-2-Amino-N-[(1S)-1-cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]cyclohexane-1-carboxamide | IC50 | 398.11 [1], 501.19 [2] |
| (1R,2S)-2-Amino-N-[(1S)-1-cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]cyclopentane-1-carboxamide | IC50 | 1000.0 [1], 1258.93 [2] |
| (1R,2R)-2-Amino-N-[(1S)-1-cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]cyclohexane-1-carboxamide | IC50 | 158.49 [1], 316.23 [2] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]morpholine-2-carboxamide | IC50 | 398.11 [1], 501.19 [2] |
| (1R,2S)-2-Amino-N-[(1S)-1-cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]cyclohexane-1-carboxamide | IC50 | 39.81 [1] |
| N-[(1S)-1-Cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]azepane-3-carboxamide | IC50 | 501.19 [1], 1258.93 [2] |
| (1R,2S)-2-Amino-N-[(1S)-1-cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]cycloheptane-1-carboxamide | IC50 | 31.62 [1], 39.81 [2] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]piperidine-2-carboxamide | IC50 | 10.0 [1], 39.81 [2] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(4-cyano-3-methylsulfanylphenyl)phenyl]ethyl]piperidine-2-carboxamide | IC50 | 1.0 [1], 3.98 [2] |
| 4-Amino-N-[(1S)-1-cyano-2-[4-(1-methyl-2-oxo-3H-indol-6-yl)phenyl]ethyl]oxane-4-carboxamide | IC50 | 0.25 [1], 1.58 [2] |
| 4-Amino-N-[(1S)-1-cyano-2-[4-(3-methylsulfonylphenyl)phenyl]ethyl]oxane-4-carboxamide | IC50 | 0.79 [1], 7.94 [2] |
| 4-Amino-N-[(1S)-1-cyano-2-[4-(2-methyl-3-oxo-1H-isoindol-5-yl)phenyl]ethyl]oxane-4-carboxamide | IC50 | 5.01 [1], 50.12 [2] |
| 1-Amino-N-[(1S)-1-cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]cyclohexane-1-carboxamide | IC50 | 2.51 [1], 3.16 [2] |
| (2S)-N-[(1S)-1-Cyano-2-(4-phenylphenyl)ethyl]piperidine-2-carboxamide | IC50 | 125.89 [1], 158.49 [2] |
| 4-Amino-N-[(1S)-1-cyano-2-(4-phenylphenyl)ethyl]oxane-4-carboxamide | IC50 | 2.0 [1], 31.62 [2] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(2-methyl-1-oxo-3H-isoindol-5-yl)phenyl]ethyl]piperidine-2-carboxamide | IC50 | 7.94 [1], 25.12 [2] |
| (2S,4S)-N-[(1S)-1-Cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]-4-hydroxypiperidine-2-carboxamide | IC50 | 5.01 [1], 12.59 [2] |
| (2S,4S)-N-[(1S)-1-Cyano-2-[4-(2-methyl-1-oxo-3H-isoindol-5-yl)phenyl]ethyl]-4-hydroxypiperidine-2-carboxamide | IC50 | 3.98 [1], 39.81 [2] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(3-methyl-2-oxo-1,3-benzothiazol-5-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 2.51 [1], 3.16 [2] |
| N-[(1S)-1-Cyano-2-[4-(3-cyano-4-methylsulfonylphenyl)-2-fluorophenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 27.8 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(3,4,5-trifluorophenyl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 243.7 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(4-ethylsulfonylphenyl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 164.4 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(2-cyanopyridin-4-yl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 248.5 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[2-fluoro-4-(2-methyl-1,3-dihydroisoindol-5-yl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 98.0 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(4-cyano-3-methylsulfonylphenyl)-2-fluorophenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 30.1 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(4-sulfamoylphenyl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 102.3 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(2-oxo-1,3-dihydroindol-5-yl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 102.8 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(4-methylsulfonylphenyl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 110.5 [1] |
| (3S)-N-[(1S)-2-[4-(4-Carbamoylphenyl)phenyl]-1-cyanoethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 118.0 [1] |
| (3S)-N-[(1S)-2-[4-(3-Carbamoylphenyl)phenyl]-1-cyanoethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 130.7 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(1-methyl-2-oxo-3H-indol-5-yl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 133.7 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(1-oxo-3,4-dihydro-2H-isoquinolin-6-yl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 136.7 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(2-oxo-1,3-dihydroindol-6-yl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 50.1 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(4-cyano-3-fluorophenyl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 66.4 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-[1-(2-methoxyethyl)-2-oxo-3H-indol-6-yl]phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 159.8 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-[4-(methanesulfonamido)phenyl]phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 123.7 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 73.0 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(3-methylsulfonylphenyl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 73.5 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(1-oxo-2,3-dihydroisoindol-5-yl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 86.7 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(4-cyano-3-methylsulfonylphenyl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 70.2 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[2-fluoro-4-(2-methyl-1,1-dioxo-3H-1,2-benzothiazol-5-yl)phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 73.3 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-[3-(methanesulfonamido)phenyl]phenyl]ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide | IC50 | 97.4 [1] |
| e-64 | IC50 | 770.0 [1] |
| Odanacatib | IC50 | 10.0 [1] |
| Morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide | IC50 | 10000.0 [1] |
| Pyrrolidine-1-carbonitrile | IC50 | 25118.86 [1] |
| 6-(3,5-Difluoroanilino)-9-(2,2-difluoroethyl)purine-2-carbonitrile | IC50 | 6918.31 [1] |
| Grassystatin A | IC50 | 10000.0 [1] |
| Cruzain-IN-1 | IC50 | 34.67 [1] |
| 9-(3,5-Difluorophenyl)-6-(ethylamino)-2-purinecarbonitrile | IC50 | 588.84 [1] |
| L-Phenylalaninamide, glycyl- | Ki | 6200000.0 [1] |
| 2-Amino-N-(benzyl-cyano-methyl)-acetamide | Ki | 2700.0 [1] |
| (2R)-2-[[(1S)-1-(4-Bromophenyl)-2,2,2-trifluoroethyl]amino]-N-(1-cyanocyclopropyl)-3-methylsulfonylpropanamide | IC50 | 10000.0 [1] |
| Gly-Phe-DMK | IC50 | 51.0 [1] |
| (3S)-1-Diazo-3-[(aminoacetyl)amino]-4-(4-iodophenyl)-2-butanone | IC50 | 1.0 [1] |
| (S)-2-Amino-N-((S)-1-cyano-3-phenylpropyl)butanamide | IC50 | 822.0 [1] |
| (S)-2-Amino-N-((S)-1-cyano-2-phenylethyl)butanamide | IC50 | 172.0 [1] |
| (S)-2-Amino-N-((S)-2-(4-chlorophenyl)-1-cyanoethyl)butanamide | IC50 | 96.0 [1] |
| (2R)-N-[(1S)-1-Cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 6309.57 [1] |
| (2S)-N-[(1S)-1-Cyano-2-[4-[4-(trifluoromethyl)phenyl]phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 39.81 [1] |
| (2S)-N-[(1S)-2-[4-(1,3-Benzothiazol-5-yl)phenyl]-1-cyanoethyl]-1,4-oxazepane-2-carboxamide | IC50 | 63.1 [1] |
| N-[(1S)-1-Cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 63.1 [1] |
| N-[2-(Cyanomethylamino)-2-oxoethyl]-3-[2-(3,5-dichlorophenyl)-2-methylpropanoyl]-4-methoxybenzamide | IC50 | 100000.0 [1] |
| N-[2-(Cyanomethylamino)-2-oxoethyl]-3-[2-(3,5-dichlorophenyl)-2-methylpropanoyl]-4-[2-(dimethylamino)ethoxy]benzamide | IC50 | 100000.0 [1] |
| N-[(2-Cyanopyrimidin-4-Yl)methyl]-3-[2-(3,5-Dichlorophenyl)-2-Methylpropanoyl]-4-Methoxybenzamide | IC50 | 66000.0 [1] |
| N-[(2-Cyanopyrimidin-4-yl)methyl]-3-[2-(3,5-dichlorophenyl)-2-methylpropanoyl]-4-[2-(dimethylamino)ethoxy]benzamide | IC50 | 18000.0 [1] |
| 3-[2-(3,5-Dichlorophenyl)-2-methylpropanoyl]-4-methoxy-N-[2-[[(E)-3-methylsulfonylprop-2-enyl]amino]-2-oxoethyl]benzamide | IC50 | 100000.0 [1] |
| (2S)-2-[[2-(3,5-Dichlorophenyl)acetyl]amino]-3,3-dimethyl-N-[2-[[(E)-3-methylsulfonylprop-2-enyl]amino]-2-oxoethyl]butanamide | IC50 | 100000.0 [1] |
| (2S)-2-[[(2S)-2-(3,5-Dichlorophenyl)-2-(ethylamino)acetyl]amino]-3,3-dimethyl-N-[2-[[(E)-3-methylsulfonylprop-2-enyl]amino]-2-oxoethyl]butanamide | IC50 | 100000.0 [1] |
| (2S)-2-(3,5-Dichlorophenyl)-N-[(3S)-1-[2-[[(E)-3-methylsulfonylprop-2-enyl]amino]-2-oxoethyl]-2-oxopyrrolidin-3-yl]butanamide | IC50 | 100000.0 [1] |
| (3R,4R)-4-(2,3-Dimethylphenoxy)piperidin-3-ol | IC50 | 100000.0 [1] |
| (3S)-N-[(1S)-1-Cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]piperidine-3-carboxamide | IC50 | 10000.0 [1] |
| (1S,2R)-2-Amino-N-[(1S)-1-cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]cyclohexane-1-carboxamide | IC50 | 10000.0 [1] |
| 2-Amino-N-[(1S)-1-cyano-2-[4-(3-cyanophenyl)phenyl]ethyl]cyclohexane-1-carboxamide | IC50 | 1000.0 [1] |
| (2S)-N-[(1S)-1-Cyano-2-[4-(4-methyl-3-oxoquinoxalin-6-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | IC50 | 25.12 [1] |
| (2R)-N-[(1S)-1-Cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]morpholine-2-carboxamide | IC50 | 10000.0 [1] |
| (3R)-N-[(1S)-1-Cyano-2-[4-(4-cyanophenyl)phenyl]ethyl]piperidine-3-carboxamide | IC50 | 10000.0 [1] |
| N-[1-[[(3S)-1-Diazo-2-oxohexan-3-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-(4-iodophenyl)benzamide | IC50 | 450.0 [1] |
| (4S,5R)-4-(2,3-Dimethylphenoxy)-6-oxa-1-azabicyclo[3.2.1]octan-7-one | IC50 | 18.0 [1] |
| cis-(S)-2-Amino-N-((1R,2R)-1-cyano-2-phenylcyclopropyl)-3-(thiophen-2-yl)propanamide | IC50 | 14.0 [1] |
| (4S,5S)-4-(2,3-Dimethylphenoxy)-6-oxa-1-azabicyclo[3.2.1]octan-7-one | IC50 | 1727.0 [1] |
| (4S,5R)-4-Phenoxy-6-oxa-1-azabicyclo[3.2.1]octan-7-one | IC50 | 29.0 [1] |
| (4S,5R)-4-Phenylmethoxy-6-oxa-1-azabicyclo[3.2.1]octan-7-one | IC50 | 403.0 [1] |
| (4S,5R)-4-(2-Methylpropoxy)-6-oxa-1-azabicyclo[3.2.1]octan-7-one | IC50 | 191.0 [1] |